SolveLabs Tremella (Tremella fuciformis) 10:1 60 Capsules

SolveLabs Tremella (Tremella fuciformis) 10:1 dietary supplement is a high-quality product containing a concentrated extract from the fruiting body of Tremella fuciformis. This mushroom is popular in the beauty industry for its skin care properties. SolveLabs' product is characterized by an extremely simple, pure, and natural formulation. It contains no artificial additives or enhancers. Additionally, it is delivered in a convenient capsule form.

The sea bream is an edible mushroom. However, its properties are used both in the kitchen and in cosmetics. In the Asian beauty industry, it holds a special place due to its many positive effects on health and skin condition.

Tremella fuciformis is a treasure trove of a variety of active substances. The most important among them are polysaccharides. These have been proven to have a protective effect on UVA-treated skin. [1]

A study investigated the effectiveness of Tremella extract in radiation protection. It was shown that the polysaccharides of Tremella can significantly reduce oxidative stress on UVA-treated human skin fibroblast cells. After taking Tremella, the content of reactive oxygen species and malondialdehyde (which cause oxidative stress) in the cell significantly decreased, and the overall antioxidant activity increased. [1]

Furthermore, it was found that Tremella fuciformis increases the content of collagen I, elastin, and hyaluronic acid in UVA-treated skin fibroblasts.

In summary, SolveLabs Tremella (Tremella fuciformis) 10:1 is a unique product containing an extract from the mushroom Tremella fuciformis, highly regarded in the cosmetics industry. This mushroom is rich in active substances that positively affect health and skin condition, among other things. SolveLabs' formulation has a pure and natural composition, free from all additives and enhancers.

1 Fu H, You S, Zhao D, An Q, Zhang J, Wang C, Wang D, Li M. Tremella fuciformis polysaccharides inhibit UVA-induced photodamage of human dermal fibroblast cells by activating up-regulating Nrf2/Keap1 pathways. J Cosmet Dermatol. 2021 Dec;20(12):4052-4059. doi: 10.1111/jocd.14051. epub 2021 Mar 25. PMID: 33686752.